Literature DB >> 19057023

Nanotechnology in medical imaging: probe design and applications.

David P Cormode1, Torjus Skajaa, Zahi A Fayad, Willem J M Mulder.   

Abstract

Nanoparticles have become more and more prevalent in reports of novel contrast agents, especially for molecular imaging, the detection of cellular processes. The advantages of nanoparticles include their potency to generate contrast, the ease of integrating multiple properties, lengthy circulation times, and the possibility to include high payloads. As the chemistry of nanoparticles has improved over the past years, more sophisticated examples of nano-sized contrast agents have been reported, such as paramagnetic, macrophage targeted quantum dots or alpha(v)beta(3)-targeted, MRI visible microemulsions that also carry a drug to suppress angiogenesis. The use of these particles is producing greater knowledge of disease processes and the effects of therapy. Along with their excellent properties, nanoparticles may produce significant toxicity, which must be minimized for (clinical) application. In this review we discuss the different factors that are considered when designing a nanoparticle probe and highlight some of the most advanced examples.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057023      PMCID: PMC2844987          DOI: 10.1161/ATVBAHA.108.165506

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  79 in total

Review 1.  Magnetic resonance and fluorescence based molecular imaging technologies.

Authors:  David Sosnovik; Ralph Weissleder
Journal:  Prog Drug Res       Date:  2005

2.  Tomographic imaging using the nonlinear response of magnetic particles.

Authors:  Bernhard Gleich; Jürgen Weizenecker
Journal:  Nature       Date:  2005-06-30       Impact factor: 49.962

3.  MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles.

Authors:  Tillmann Cyrus; Dana R Abendschein; Shelton D Caruthers; Thomas D Harris; Veronica Glattauer; Jerome A Werkmeister; John A M Ramshaw; Samuel A Wickline; Gregory M Lanza
Journal:  J Cardiovasc Magn Reson       Date:  2006       Impact factor: 5.364

4.  Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.

Authors:  Patrick M Winter; Kejia Cai; Junjie Chen; Christopher R Adair; Garry E Kiefer; Phillip S Athey; Patrick J Gaffney; Carolyn E Buff; J David Robertson; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Journal:  Magn Reson Med       Date:  2006-12       Impact factor: 4.668

Review 5.  Molecular imaging and therapy of atherosclerosis with targeted nanoparticles.

Authors:  Samuel A Wickline; Anne M Neubauer; Patrick M Winter; Shelton D Caruthers; Gregory M Lanza
Journal:  J Magn Reson Imaging       Date:  2007-04       Impact factor: 4.813

6.  Forming biocompatible and nonaggregated nanocrystals in water using amphiphilic polymers.

Authors:  William W Yu; Emmanuel Chang; Joshua C Falkner; Junyan Zhang; Ali M Al-Somali; Christie M Sayes; Judah Johns; Rebekah Drezek; Vicki L Colvin
Journal:  J Am Chem Soc       Date:  2007-02-20       Impact factor: 15.419

7.  Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.

Authors:  Matthias Nahrendorf; Farouc A Jaffer; Kimberly A Kelly; David E Sosnovik; Elena Aikawa; Peter Libby; Ralph Weissleder
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

8.  Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.

Authors:  Patrick M Winter; Shelton D Caruthers; Huiying Zhang; Todd A Williams; Samuel A Wickline; Gregory M Lanza
Journal:  JACC Cardiovasc Imaging       Date:  2008-09

Review 9.  Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.

Authors:  Karen C Briley-Saebo; Willem J M Mulder; Venkatesh Mani; Fabien Hyafil; Vardan Amirbekian; Juan Gilberto S Aguinaldo; Edward A Fisher; Zahi A Fayad
Journal:  J Magn Reson Imaging       Date:  2007-09       Impact factor: 4.813

10.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells.

Authors:  F S Villanueva; R J Jankowski; S Klibanov; M L Pina; S M Alber; S C Watkins; G H Brandenburger; W R Wagner
Journal:  Circulation       Date:  1998-07-07       Impact factor: 29.690

View more
  77 in total

Review 1.  Imaging and drug delivery using theranostic nanoparticles.

Authors:  Siti M Janib; Ara S Moses; J Andrew MacKay
Journal:  Adv Drug Deliv Rev       Date:  2010-08-13       Impact factor: 15.470

Review 2.  The current state of engineered nanomaterials in consumer goods and waste streams: the need to develop nanoproperty-quantifiable sensors for monitoring engineered nanomaterials.

Authors:  Kelsey Wise; Murphy Brasuel
Journal:  Nanotechnol Sci Appl       Date:  2011-07-01

Review 3.  Theranostics and metabolotheranostics for precision medicine in oncology.

Authors:  Zaver M Bhujwalla; Samata Kakkad; Zhihang Chen; Jiefu Jin; Sudath Hapuarachchige; Dmitri Artemov; Marie-France Penet
Journal:  J Magn Reson       Date:  2018-04-26       Impact factor: 2.229

Review 4.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

5.  Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation.

Authors:  M M Stollenwerk; I Pashkunova-Martic; C Kremser; H Talasz; G C Thurner; A A Abdelmoez; E A Wallnöfer; A Helbok; E Neuhauser; N Klammsteiner; L Klimaschewski; E von Guggenberg; E Fröhlich; B Keppler; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-02-20       Impact factor: 4.304

6.  Accumulation of nano-sized particles in a murine model of angiogenesis.

Authors:  Thomas R Wittenborn; Esben K U Larsen; Thomas Nielsen; Louise M Rydtoft; Line Hansen; Jens V Nygaard; Thomas Vorup-Jensen; Jørgen Kjems; Michael R Horsman; Niels Chr Nielsen
Journal:  Biochem Biophys Res Commun       Date:  2013-12-07       Impact factor: 3.575

Review 7.  Modified natural nanoparticles as contrast agents for medical imaging.

Authors:  David P Cormode; Peter A Jarzyna; Willem J M Mulder; Zahi A Fayad
Journal:  Adv Drug Deliv Rev       Date:  2009-11-06       Impact factor: 15.470

8.  Imaging of angiogenesis.

Authors:  Willem J M Mulder; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2010-06       Impact factor: 9.596

Review 9.  Optical and multimodality molecular imaging: insights into atherosclerosis.

Authors:  Farouc A Jaffer; Peter Libby; Ralph Weissleder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04-09       Impact factor: 8.311

Review 10.  Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

Authors:  C Shad Thaxton; Jonathan S Rink; Pratap C Naha; David P Cormode
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.